Joe Chehade

CTA Phase 2/3 multicenter, double blinded, randomized, dose-conversion, active control study examining the efficacy and safety of Armour Thyroid compared to synthetic T4 for the treatment of adults with primary hypothyroidism

Testosterone Replacement therapy for Assessment of long-termVascular Events and efficacy ResponSE in hypogonadal men (TRAVERSE) Study

A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effect of Efpeglenatide on Cardiovascular Outcomes in Type 2 Diabetes Patients at High Cardiovascular Risk

Safety and Efficacy of BIO-101 175 mg b.i.d. and 350 mg b.i.d. 26-week oral administration to patients suffering from age-related SARcopenia, including sarcopenic obesity, Aged >65 years and at risk of mobility disability. A double-blind, placebo controlled, randomized INTerventional Clinical Trial

A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotagliflozin on Cardiovascular and Renal Events in Patients with Type 2 Diabetes, Cardiovascular Risk Factors and Moderately Impaired Renal Function

A PHASE III, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER STUDY TO ASSESS THE SAFETY AND EFFICACY OF VM202 IN SUBJECTS WITH PAINFUL DIABETIC PERIPHERAL NEUROPATHY

A RANDOMISED, DBL-BLIND, PLACEBO-CONTROLLED PARALLEL GROUP EFFICACY AND SAFETY STUDY OF EMPAGLIFLOZIN (10MG, 25MG)....

CLIA WAIVER STUDY COBAS B 101 ANALYZER WITH HBA1C ASSAY

A 52-WEEK INTERNATIONAL MULTICENTER RANDOMIZED DOUBLE BLIND ACTIVE CONTROLLED PARALLEL GROUP PHASE 3BTRIAL WITH A BLIND

A 24-WEEK INTERNATIONAL, MULTICENTER, RANDOMIZED, OPEN-LABELACTIVE-CONTROLLED, PARALLEL GROUP, PHASE 3B TRIAL WITH A....

A TRIAL COMPARING CARDIOVASCULAR SAFETY OF INSULIN DEGLUDEC VERSUS INSULIN GLARGINE IN SUBJECTS WITH TYPE 2 DIABETES....

A PHASE 3 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF TRIPLE THERAPY WITH SAXAGLIPTIN AND TO DAPAGLIFLOZIN ......